Fresenius Medical Care AG & Co. KGaA
FMS · NYSE
12/31/2024 | 12/31/2023 | 12/31/2022 | 12/31/2021 | |
|---|---|---|---|---|
| Valuation | ||||
| PEG Ratio | 3.12 | -0.87 | -0.44 | -1.05 |
| FCF Yield | 13.12% | 17.23% | 8.45% | 4.82% |
| EV / EBITDA | 7.07 | 6.84 | 13.22 | 8.05 |
| Quality | ||||
| ROIC | 3.35% | 3.30% | -0.61% | 0.79% |
| Gross Margin | 24.60% | 25.32% | 27.37% | 28.82% |
| Cash Conversion Ratio | 3.22 | 3.59 | 2.42 | 2.04 |
| Growth | ||||
| Revenue 3-Year CAGR | -0.11% | 3.36% | 2.79% | 0.27% |
| Free Cash Flow Growth | -13.24% | 157.17% | -6.20% | -62.42% |
| Safety | ||||
| Net Debt / EBITDA | 3.06 | 3.33 | 7.56 | 3.34 |
| Interest Coverage | 3.42 | 3.22 | -0.72 | 0.85 |
| Efficiency | ||||
| Inventory Turnover | 7.05 | 6.67 | 6.14 | 6.15 |
| Cash Conversion Cycle | 91.48 | 100.77 | 104.83 | 108.53 |